Effect of adjuvants on orally administered antigens.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D005260:Female; D007108:Immune Tolerance; D007114:Immunization; D007070:Immunoglobulin A / Q000096:biosynthesis*; D007413:Intestinal Mucosa / Q000276:immunology* / Q000378:metabolism; D008081:Liposomes / Q000008:administration & dosage / Q000494:pharmacology; D008213:Lymphocyte Activation; D009061:Mouth Mucosa / Q000276:immunology / Q000378:metabolism; D010581:Peyer's Patches / Q000276:immunology; D011817:Rabbits; D051381:Rats; D012463:Saliva / Q000276:immunology; D012710:Serum Albumin, Bovine / Q000008:administration & dosage / Q000276:immunology
D000276:Adjuvants, Immunologic; D000941:Antigens; D007070:Immunoglobulin A; D008081:Liposomes; D012710:Serum Albumin, Bovine; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C035295:6-O-stearoyl-N-acetylmuramyl-alanylisoglutamine